| |
| |
|
| Insider
Information: |
Mulroy Robert J. |
| Relationship: |
President and CEO, Dir... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,683,328 |
|
|
Indirect Shares
|
931,354 |
|
|
| Direct
Value |
$25,249,920 |
|
|
|
Indirect Value
|
$13,970,310 |
|
|
| Total
Shares |
2,614,682 |
|
|
| Total
Value |
$39,220,230 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merrimack Pharmaceuticals Inc |
MACK |
President and CEO, Dir... |
2015-03-24 |
1,683,328 |
2013-12-02 |
931,354 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2015-03-24 |
4 |
OE |
$1.71 |
$868,479 |
D/D |
447,980 |
1,683,328 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2015-03-24 |
4 |
S |
$11.71 |
$1,217,465 |
D/D |
(103,968) |
1,509,316 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2015-03-23 |
4 |
S |
$11.69 |
$121,576 |
D/D |
(10,400) |
1,339,316 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2015-03-23 |
4 |
OE |
$1.71 |
$17,784 |
D/D |
10,400 |
1,349,716 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2015-03-05 |
4 |
AS |
$12.50 |
$279,813 |
D/D |
(22,385) |
1,339,316 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2015-03-05 |
4 |
OE |
$1.71 |
$38,278 |
D/D |
22,385 |
1,361,701 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2015-02-20 |
4 |
OE |
$1.71 |
$256,500 |
D/D |
150,000 |
1,489,316 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2015-02-20 |
4 |
AS |
$10.94 |
$1,641,000 |
D/D |
(150,000) |
1,339,316 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2014-12-08 |
4 |
OE |
$1.25 |
$167,702 |
D/D |
118,247 |
1,339,316 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2014-12-08 |
4 |
S |
$9.73 |
$243,250 |
D/D |
(25,000) |
1,270,232 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2014-12-05 |
4 |
S |
$9.85 |
$1,723,750 |
D/D |
(175,000) |
1,246,069 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2014-12-05 |
4 |
OE |
$1.25 |
$218,750 |
D/D |
175,000 |
1,421,069 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2014-08-29 |
4 |
OE |
$1.25 |
$24,790 |
D/D |
19,832 |
1,246,069 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2014-08-21 |
4 |
OE |
$1.25 |
$350,210 |
D/D |
280,168 |
1,226,237 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2014-05-05 |
4 |
B |
$6.31 |
$31,550 |
D/D |
5,000 |
946,069 |
2.81 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2013-12-04 |
4 |
B |
$4.42 |
$146,226 |
D/D |
33,100 |
989,644 |
2.81 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2013-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,715 |
941,069 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2013-12-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(58,290) |
931,354 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2013-05-06 |
4 |
OE |
$2.19 |
$109,500 |
D/D |
50,000 |
956,544 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2013-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
7,443 |
848,254 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2013-01-04 |
4 |
A |
$0.00 |
$0 |
I/I |
58,290 |
906,544 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2012-06-15 |
4 |
OE |
$2.19 |
$164,250 |
D/D |
75,000 |
680,819 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2012-06-15 |
5 |
OE |
$2.19 |
$164,250 |
D/D |
75,000 |
840,811 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEO |
• • – |
2012-04-03 |
5 |
A |
$0.00 |
$0 |
I/I |
159,992 |
765,811 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
President and CEOOfficer |
• • – |
2012-01-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
474,603 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
